What You're Actually Buying When You Pay for a Peptide Therapy Clinic

You've done the reading. You know the difference between CJC-1295 and ipamorelin, you've seen the before/after threads on the longevity forums, and you're now staring at consultation fees that range from $150 to $600 before a single vial ships. The question isn't whether peptide therapy is real — the clinical literature on growth hormone secretagogues is reasonably solid — it's whether the clinic charging you $450/month is delivering meaningfully more than the one charging $180.

What the Market Actually Looks Like in 2026

The peptide clinic space has consolidated since the FDA's 2024 compounding crackdown, but it hasn't tidied up. You've still got brick-and-mortar anti-aging clinics, hybrid practices with an in-person intake and mail-order compounding, and fully async telehealth platforms that issue a protocol after a short intake form and a bloodwork upload.

Pricing for a standard GH secretagogue stack — typically CJC-1295 paired with ipamorelin — runs $180–$350/month at most telehealth-first platforms. Full-service in-person clinics in major metros often start at $500/month once you factor in monthly monitoring visits. The price gap isn't always explained by better outcomes; it's often explained by real estate and physician overhead. Fully online peptide programs have closed much of the quality gap for straightforward protocols because the marginal cost of physician oversight per patient is lower.

The Bloodwork Question Nobody Wants to Answer Clearly

A credible clinic orders labs before writing a protocol. For growth hormone optimization, that means, at minimum, IGF-1 (reference range typically 115–307 ng/mL for adults aged 30–50), fasting glucose, and a lipid panel. Some will add a baseline GH stimulation test for patients over 45. If a clinic skips IGF-1 and goes straight to a peptide recommendation based on symptom questionnaires alone, that's a workflow designed for throughput, not for you.

An IGF-1 at the lower end of normal — say, 118 ng/mL — doesn't automatically mean you need a secretagogue. It means you need a clinician who will interpret that number against your sleep quality, body composition, cortisol levels, and thyroid function, not one who ticks a box and defaults to sermorelin at 200 mcg nightly because that's the standard template.

How to Read a Clinic's Protocol Without Being a Clinician

Dosing ranges are publicly documented enough that you can sanity-check what you're being offered. Sermorelin is typically dosed at 200–500 mcg subcutaneously before bed. CJC-1295 without DAC is commonly used at 100–300 mcg per injection, two to three times weekly. If a clinic prescribes above these ranges without documented rationale — or gives you a 50 mcg dose and calls it therapeutic — ask why in writing.

The same logic applies to injury and recovery protocols. BPC-157, a gut and connective tissue peptide with a published body of animal data and a smaller set of human observational reports, is typically used at 250–500 mcg/day. Clinics that can't name their compounding source or refuse to provide a certificate of analysis for their peptides are disqualifying themselves.

What the FDA Shift Has Actually Changed

The FDA's reclassification of certain peptides — including BPC-157 — from the 503A compounding category disrupted the domestic supply chain. Peptides didn't disappear; the compliance picture got more complicated. Clinics that adapted by working with 503B outsourcing facilities and clinics that pivoted to internationally sourced compounds are now operating in meaningfully different regulatory environments.

The practical consequence: ask your clinic whether their peptides come from an FDA-registered 503A or 503B facility, and get that answer in writing. Clinics that can't answer the question directly — or pivot to "pharmaceutical-grade" without specifying what that means under 21 CFR Part 207 — warrant caution.

What Separates the Clinics Worth Paying For

Across the range of online peptide programs and in-person clinics, a few operational markers separate serious practices from volume shops:

Follow-up bloodwork is built into the protocol, not upsold. A 90-day IGF-1 recheck should be standard after starting a GH secretagogue. If it's a $95 add-on rather than a baseline expectation, that tells you something about how the clinic is structured.

The physician is reachable. Not a coordinator, not a chatbot — a clinician who can respond to a specific question about your labs within 48 hours.

They'll tell you when peptides aren't the right tool. A clinic that pushes peptides to every patient who completes an intake is not practicing medicine. A clinic that occasionally refers patients to an endocrinologist or recommends lifestyle changes before initiating a protocol probably is.

System Labs and Yucca Health are two telehealth-first platforms worth comparing directly if you're in the US market — both have transparent pricing structures and documented compounding partnerships, which is more than can be said for much of the space.

The Actual Takeaway

If you're spending more than $300/month on a peptide protocol, you should be getting monitored bloodwork at 90-day intervals, a clinician who can contextualise your IGF-1 or inflammatory markers, and documented compound sourcing. If any of those three things are missing, you're not paying for clinical oversight — you're paying for a subscription with a prescription attached. The peptide clinics directory lets you filter by protocol type and service model, which is faster than reading five clinics' marketing pages in sequence.

The clinics worth using in two years are the ones that treat your bloodwork as the product, not the peptides.

---

Peptide Clinic Finder is a comparison platform. The author may receive compensation if you sign up through links on our partner pages.

---